PLUVICTO - Northern California VA
Veterans Affairs · 261-NETWORK CONTRACT OFFICE 21 (36C261)
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26127N0055 in this department, oldest first.
- Oct 1, 2026 · this noticeAward NoticeNovartis Pharmaceuticals Corporation · $3.1M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Awardee: NOVARTIS PHARMACEUTICALS CORPORATION Award Amount: $3,086,483.40 (including option to increase quantity) Period of Performance: 10/01/2026 - 09/30/2027 Limited Source Justification is attached.
Who won similar work
7 award notices on SAM.gov in the last 24 months. Matched by: Same office (261-NETWORK CONTRACT OFFICE 21 (36C261)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (7): middle half $476K to $1.7M, median $957K; range $30K to $4.1M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| RLS (USA) INC. | 2 | $3.4M | Apr 4, 2025 |
| BIOLOGICS, INC. | 2 | $107K | Oct 14, 2025 |
| Novartis Pharmaceuticals Corporation | 1 | $4.1M | Oct 1, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $226.8B | 1 | $957K | Aug 14, 2025 |
| JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | 1 | $875K | Sep 14, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $226.8B revenue in FY2026. The median single-winner award in these 7 past awards, $957K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026Novartis Pharmaceuticals Corporation$4.1MPLUVICTO Palo Alto VANo listed company matched (Materiality N/A)
- Sep 14, 2026JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.$875KRadiopharmaceuticals - San Francisco VANo listed company matched (Materiality N/A)
- Oct 14, 2025BIOLOGICS, INC.$30KLENALIDOMIDENo listed company matched (Materiality N/A)
- Sep 9, 2025BIOLOGICS, INC.$77KLENALIDOMIDENo listed company matched (Materiality N/A)
- Aug 14, 2025CARDINAL HEALTH 414, LLC$957KRadiopharmaceuticals and Related Supplies - Fresno, CAMateriality: <0.01% of $CAH revenue (Low) SEC
- Apr 4, 2025RLS (USA) INC.$2.2M6505--NON Cyclotron Radiopharmaceuticals 04/01/2029 - 03/31/2030 36C26125D0032No listed company matched (Materiality N/A)
- Dec 11, 2024RLS (USA) INC.$1.2M6505--VA Northern California Health Care System - VAMC Martinez Radiopharmaceuticals & Radiopharmaceutical SuppliesNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.